Patrick R. Trucchio
Stock Analyst at HC Wainwright & Co.
(3.79)
# 733
Out of 4,984 analysts
16
Total ratings
66.67%
Success rate
7.61%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Patrick R. Trucchio
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| SLN Silence Therapeutics | Reiterates: Buy | $75 | $5.05 | +1,385.06% | 1 | Sep 16, 2025 | |
| VIR Vir Biotechnology | Reiterates: Buy | $15 | $4.91 | +205.50% | 1 | Sep 15, 2025 | |
| BEAM Beam Therapeutics | Reiterates: Buy | $80 | $23.24 | +244.23% | 1 | Sep 15, 2025 | |
| VYGR Voyager Therapeutics | Reiterates: Buy | $30 | $4.34 | +591.24% | 1 | Sep 15, 2025 | |
| DRUG Bright Minds Biosciences | Reiterates: Buy | $85 | $46.00 | +84.78% | 2 | Sep 15, 2025 | |
| ALGS Aligos Therapeutics | Reiterates: Buy | $50 | $9.30 | +437.63% | 2 | Sep 12, 2025 | |
| QURE uniQure | Reiterates: Buy | $70 | $14.88 | +370.43% | 2 | Sep 8, 2025 | |
| NRXP NRx Pharmaceuticals | Assumes: Buy | $40 | $3.01 | +1,231.11% | 1 | Sep 8, 2025 | |
| SGMO Sangamo Therapeutics | Reiterates: Buy | $10 | $0.51 | +1,851.60% | 1 | Sep 4, 2025 | |
| ALNY Alnylam Pharmaceuticals | Reiterates: Buy | $570 | $461.44 | +23.53% | 1 | Sep 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $80 | $29.59 | +170.36% | 1 | Sep 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $5 | $1.23 | +306.50% | 1 | Aug 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $10 | $3.91 | +156.08% | 1 | Aug 18, 2025 |
Silence Therapeutics
Sep 16, 2025
Reiterates: Buy
Price Target: $75
Current: $5.05
Upside: +1,385.06%
Vir Biotechnology
Sep 15, 2025
Reiterates: Buy
Price Target: $15
Current: $4.91
Upside: +205.50%
Beam Therapeutics
Sep 15, 2025
Reiterates: Buy
Price Target: $80
Current: $23.24
Upside: +244.23%
Voyager Therapeutics
Sep 15, 2025
Reiterates: Buy
Price Target: $30
Current: $4.34
Upside: +591.24%
Bright Minds Biosciences
Sep 15, 2025
Reiterates: Buy
Price Target: $85
Current: $46.00
Upside: +84.78%
Aligos Therapeutics
Sep 12, 2025
Reiterates: Buy
Price Target: $50
Current: $9.30
Upside: +437.63%
uniQure
Sep 8, 2025
Reiterates: Buy
Price Target: $70
Current: $14.88
Upside: +370.43%
NRx Pharmaceuticals
Sep 8, 2025
Assumes: Buy
Price Target: $40
Current: $3.01
Upside: +1,231.11%
Sangamo Therapeutics
Sep 4, 2025
Reiterates: Buy
Price Target: $10
Current: $0.51
Upside: +1,851.60%
Alnylam Pharmaceuticals
Sep 2, 2025
Reiterates: Buy
Price Target: $570
Current: $461.44
Upside: +23.53%
Sep 2, 2025
Reiterates: Buy
Price Target: $80
Current: $29.59
Upside: +170.36%
Aug 27, 2025
Reiterates: Buy
Price Target: $5
Current: $1.23
Upside: +306.50%
Aug 18, 2025
Reiterates: Buy
Price Target: $10
Current: $3.91
Upside: +156.08%